![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
LETTERS TO THE EDITOR
Minerva Medica 2021 April;112(2):310-2
DOI: 10.23736/S0026-4806.19.06236-0
Copyright © 2019 EDIZIONI MINERVA MEDICA
language: English
Efficacy and safety of cyclophosphamide, doxorubicin, vincristine, and prednisone regimen with pegylated liposomal doxorubicin±rituximab in treating diffuse large B-cell lymphoma
Yuhuan GAO 1, Yan XIE 2, Lihong LIU 1, Hongwei XUE 3, Ming HOU 4, Mingzhi ZHANG 5, Zeping ZHOU 6, Pengxiang GUO 7, Hongxia YAO 8, Zonghong SHAO 9, Xiaobao XIE 10, Jun ZHU 2 ✉
1 Department of Hematology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China; 2 Department of Lymphoma Medicine, Beijing Cancer Hospital, Beijing, China; 3 Department of Oncology, Affiliated Hospital of Medical College of Qingdao University, Qingdao, China; 4 Department of Hematology, Qilu Hospital, Shandong University, Jinan, China; 5 Department of Oncology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 6 Department of Hematology, Second Affiliated Hospital of Kunming Medical University, Kunming, China; 7 Department of Hematology, Guizhou People’s Hospital, Guizhou, China; 8 Department of Hematology, Hainan Provincial People’s Hospital, Hainan, China; 9 Department of Hematology, General Hospital of Tianjin Medical University, Tianjin, China; 10 Department of Hematology, Changzhou First People’s Hospital, Changzhou, China